Showing results (1-10 of 524) with videos related to

Sort By:
Pageof 53
Bioorganic & Medicinal Chemistry Letters|August 9, 2012
High-affinity and selective dopamine D₃ receptor full agonistsJianyong Chen, Beth Levant, Shaomeng Wang
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubilityJianyong Chen, Ke Ding, Beth Levant, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2004
Design, synthesis, and evaluation of hexahydrobenz[f]isoquinolines as a novel class of dopamine 3 receptor ligandsXihan Wu, Jianyong Chen, Min Ji, et al.
ACS Medicinal Chemistry Letters|November 30, 2011
CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full AgonistJianyong Chen, Gregory T Collins, Beth Levant, et al.
Journal of Medicinal Chemistry|May 23, 2014
Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonistsJianyong Chen, Beth Levant, Cheng Jiang, et al.
Psychopharmacology|January 6, 2011
Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivityGregory T Collins, Yen Nhu-Thi Truong, Beth Levant, et al.
Journal of Medicinal Chemistry|September 13, 2008
Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profileJianyong Chen, Gregory T Collins, Jian Zhang, et al.
Journal of Medicinal Chemistry|April 29, 2005
Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligandsKe Ding, Jianyong Chen, Min Ji, et al.
Pageof 53